1. Home
  2. STIM vs VWAV Comparison

STIM vs VWAV Comparison

Compare STIM & VWAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neuronetics Inc.

STIM

Neuronetics Inc.

HOLD

Current Price

$2.09

Market Cap

120.4M

Sector

Health Care

ML Signal

HOLD

VWAV

VisionWave Holdings Inc.

HOLD

Current Price

$1.32

Market Cap

139.7M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
STIM
VWAV
Founded
2003
2024
Country
United States
United States
Employees
N/A
12
Industry
Medical/Dental Instruments
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
120.4M
139.7M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
STIM
VWAV
Price
$2.09
$1.32
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
2.1M
633.2K
Earning Date
05-05-2026
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
57.25
N/A
EPS
N/A
N/A
Revenue
$52,776,000.00
N/A
Revenue This Year
$11.10
N/A
Revenue Next Year
$11.92
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.80
$1.20
52 Week High
$4.00
$15.80

Technical Indicators

Market Signals
Indicator
STIM
VWAV
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
STIM
VWAV

About STIM Neuronetics Inc.

Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.

About VWAV VisionWave Holdings Inc.

VisionWave Holdings Inc is a technology company focused on the development and commercialization of artificial intelligence (AI) and autonomous solutions across air, ground and sea environments. Through its subsidiary, the Company designs and deploys technologies including radars, radio frequency (RF) sensing, unmanned aerial and ground systems, remote weapon stations and active protection systems for defense, military, homeland security and industrial applications. Its proprietary AI engine supports autonomous decision-making and product lines at various stages of development and commercialization. Revenue is generated through product sales, technology licensing, strategic alliances and joint ventures, with products including C-UAS, multi-purpose autonomous UAS and Vision-AI technology.

Share on Social Networks: